Aarti Pharmalabs Limited
PMS fund manager Unifi Capital bought 9.15 lakh shares of Aarti Pharmalabs for ₹75.03 Cr through a bulk deal on the NSE at ₹820 apiece.
A pharmaceutical and nutraceutical manufacturer, Aarti Pharmalabs produces active pharmaceutical ingredients and finished dosage forms for domestic and international markets. The company specializes in contract manufacturing and custom synthesis services across multiple therapeutic segments including oncology, cardiology, and gastroenterology. Incorporated in 2019, it operates manufacturing facilities designed to meet stringent regulatory standards for pharmaceutical production and quality assurance.
Chennai-based founded in 2001 by K Sarath Reddy. Runs thematic, niche strategies in Indian capital markets. One of India's largest pure-PMS firms by AUM.
